APO Research
Talk to an analyst

APO RESEARCH · REPORT

Wearable Injectors and Connected Devices

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Wearable Injectors and Connected Devices Market Outlook and Growth Opportunities 2026

4 July 2026206 pages

Choose your research edition.

Industry ResearchWearable Injectors and Connected Devices Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Wearable Injectors and Connected Devices Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Wearable Injectors and Connected Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Wearable Injectors and Connected Devices Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Wearable Injectors and Connected Devices Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Wearable Injectors and Connected Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Wearable Injectors and Connected Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Wearable Injectors and Connected Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Wearable Injectors and Connected Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Wearable Injectors and Connected Devices market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Wearable Injectors and Connected Devices market include Roche, Ypsomed, West Pharma, United Therapeutics, Unilife Corporation, Sonceboz, ScPharmaceuticals, Owen Mumford and Noble International, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Wearable Injectors and Connected Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Wearable Injectors and Connected Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Wearable Injectors and Connected Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Wearable Injectors and Connected Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Wearable Injectors and Connected Devices Segment by Company

Roche

Ypsomed

West Pharma

United Therapeutics

Unilife Corporation

Sonceboz

ScPharmaceuticals

Owen Mumford

Noble International

Insulet

Gerresheimer

Enable Injections

Elcam Medical

Eitan Medical

CeQur

BD Medical

Amgen

Wearable Injectors and Connected Devices Segment by Type

Disposable

Reusable

Wearable Injectors and Connected Devices Segment by Application

Home Care Settings

Hospitals

Clinics

Others

Wearable Injectors and Connected Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Wearable Injectors and Connected Devices status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Wearable Injectors and Connected Devices market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Wearable Injectors and Connected Devices significant trends, drivers, influence factors in global and regions.

6. To analyze Wearable Injectors and Connected Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Wearable Injectors and Connected Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Wearable Injectors and Connected Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Wearable Injectors and Connected Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Wearable Injectors and Connected Devices market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Wearable Injectors and Connected Devices industry.

Chapter 3: Detailed analysis of Wearable Injectors and Connected Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Wearable Injectors and Connected Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Wearable Injectors and Connected Devices in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Wearable Injectors and Connected Devices Industry Trends Table 2. Wearable Injectors and Connected Devices Industry Drivers Table 3. Wearable Injectors and Connected Devices Industry Opportunities and Challenges Table 4. Wearable Injectors and Connected Devices Industry Restraints Table 5. Global Wearable Injectors and Connected Devices Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Wearable Injectors and Connected Devices Revenue Share by Company (2021-2026) Table 7. Global Wearable Injectors and Connected Devices Sales Volume by Company (k units) & (2021-2026) Table 8. Global Wearable Injectors and Connected Devices Sales Volume Share by Company (2021-2026) Table 9. Global Wearable Injectors and Connected Devices Average Price (USD/unit) of Company (2021-2026) Table 10. Global Wearable Injectors and Connected Devices Company Ranking, (2024-2026) & (USD Million) Table 11. Global Wearable Injectors and Connected Devices Key Company Manufacturing Base & Headquarters Table 12. Global Wearable Injectors and Connected Devices Company, Product Type & Application Table 13. Global Wearable Injectors and Connected Devices Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Wearable Injectors and Connected Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Disposable Table 18. Significant Companies of Reusable Table 19. Global Wearable Injectors and Connected Devices Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Wearable Injectors and Connected Devices Sales Volume by Type (2021-2026) & (k units) Table 21. Global Wearable Injectors and Connected Devices Sales Volume by Type (2027-2032) & (k units) Table 22. Global Wearable Injectors and Connected Devices Sales Volume Share by Type (2021-2026) Table 23. Global Wearable Injectors and Connected Devices Sales Volume Share by Type (2027-2032) Table 24. Global Wearable Injectors and Connected Devices Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Wearable Injectors and Connected Devices Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Wearable Injectors and Connected Devices Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Wearable Injectors and Connected Devices Sales Value Share by Type (2021-2026) Table 28. Global Wearable Injectors and Connected Devices Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Home Care Settings Table 30. Significant Companies of Hospitals Table 31. Significant Companies of Clinics Table 32. Significant Companies of Others Table 33. Global Wearable Injectors and Connected Devices Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Wearable Injectors and Connected Devices Sales Volume by Application (2021-2026) & (k units) Table 35. Global Wearable Injectors and Connected Devices Sales Volume by Application (2027-2032) & (k units) Table 36. Global Wearable Injectors and Connected Devices Sales Volume Share by Application (2021-2026) Table 37. Global Wearable Injectors and Connected Devices Sales Volume Share by Application (2027-2032) Table 38. Global Wearable Injectors and Connected Devices Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Wearable Injectors and Connected Devices Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Wearable Injectors and Connected Devices Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Wearable Injectors and Connected Devices Sales Value Share by Application (2021-2026) Table 42. Global Wearable Injectors and Connected Devices Sales Value Share by Application (2027-2032) Table 43. Global Wearable Injectors and Connected Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Wearable Injectors and Connected Devices Sales by Region (2021-2026) & (k units) Table 45. Global Wearable Injectors and Connected Devices Sales Market Share by Region (2021-2026) Table 46. Global Wearable Injectors and Connected Devices Sales by Region (2027-2032) & (k units) Table 47. Global Wearable Injectors and Connected Devices Sales Market Share by Region (2027-2032) Table 48. Global Wearable Injectors and Connected Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Wearable Injectors and Connected Devices Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Wearable Injectors and Connected Devices Sales Value Share by Region (2021-2026) Table 51. Global Wearable Injectors and Connected Devices Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Wearable Injectors and Connected Devices Sales Value Share by Region (2027-2032) Table 53. Global Wearable Injectors and Connected Devices Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Wearable Injectors and Connected Devices Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Wearable Injectors and Connected Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Wearable Injectors and Connected Devices Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Wearable Injectors and Connected Devices Sales by Country (2021-2026) & (k units) Table 58. Global Wearable Injectors and Connected Devices Sales Market Share by Country (2021-2026) Table 59. Global Wearable Injectors and Connected Devices Sales by Country (2027-2032) & (k units) Table 60. Global Wearable Injectors and Connected Devices Sales Market Share by Country (2027-2032) Table 61. Global Wearable Injectors and Connected Devices Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Wearable Injectors and Connected Devices Sales Value Market Share by Country (2021-2026) Table 63. Global Wearable Injectors and Connected Devices Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Wearable Injectors and Connected Devices Sales Value Market Share by Country (2027-2032) Table 65. Roche Company Information Table 66. Roche Business Overview Table 67. Roche Wearable Injectors and Connected Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Roche Wearable Injectors and Connected Devices Product Portfolio Table 69. Roche Recent Development Table 70. Ypsomed Company Information Table 71. Ypsomed Business Overview Table 72. Ypsomed Wearable Injectors and Connected Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Ypsomed Wearable Injectors and Connected Devices Product Portfolio Table 74. Ypsomed Recent Development Table 75. West Pharma Company Information Table 76. West Pharma Business Overview Table 77. West Pharma Wearable Injectors and Connected Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. West Pharma Wearable Injectors and Connected Devices Product Portfolio Table 79. West Pharma Recent Development Table 80. United Therapeutics Company Information Table 81. United Therapeutics Business Overview Table 82. United Therapeutics Wearable Injectors and Connected Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. United Therapeutics Wearable Injectors and Connected Devices Product Portfolio Table 84. United Therapeutics Recent Development Table 85. Unilife Corporation Company Information Table 86. Unilife Corporation Business Overview Table 87. Unilife Corporation Wearable Injectors and Connected Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Unilife Corporation Wearable Injectors and Connected Devices Product Portfolio Table 89. Unilife Corporation Recent Development Table 90. Sonceboz Company Information Table 91. Sonceboz Business Overview Table 92. Sonceboz Wearable Injectors and Connected Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Sonceboz Wearable Injectors and Connected Devices Product Portfolio Table 94. Sonceboz Recent Development Table 95. ScPharmaceuticals Company Information Table 96. ScPharmaceuticals Business Overview Table 97. ScPharmaceuticals Wearable Injectors and Connected Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. ScPharmaceuticals Wearable Injectors and Connected Devices Product Portfolio Table 99. ScPharmaceuticals Recent Development Table 100. Owen Mumford Company Information Table 101. Owen Mumford Business Overview Table 102. Owen Mumford Wearable Injectors and Connected Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Owen Mumford Wearable Injectors and Connected Devices Product Portfolio Table 104. Owen Mumford Recent Development Table 105. Noble International Company Information Table 106. Noble International Business Overview Table 107. Noble International Wearable Injectors and Connected Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Noble International Wearable Injectors and Connected Devices Product Portfolio Table 109. Noble International Recent Development Table 110. Insulet Company Information Table 111. Insulet Business Overview Table 112. Insulet Wearable Injectors and Connected Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Insulet Wearable Injectors and Connected Devices Product Portfolio Table 114. Insulet Recent Development Table 115. Gerresheimer Company Information Table 116. Gerresheimer Business Overview Table 117. Gerresheimer Wearable Injectors and Connected Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Gerresheimer Wearable Injectors and Connected Devices Product Portfolio Table 119. Gerresheimer Recent Development Table 120. Enable Injections Company Information Table 121. Enable Injections Business Overview Table 122. Enable Injections Wearable Injectors and Connected Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Enable Injections Wearable Injectors and Connected Devices Product Portfolio Table 124. Enable Injections Recent Development Table 125. Elcam Medical Company Information Table 126. Elcam Medical Business Overview Table 127. Elcam Medical Wearable Injectors and Connected Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Elcam Medical Wearable Injectors and Connected Devices Product Portfolio Table 129. Elcam Medical Recent Development Table 130. Eitan Medical Company Information Table 131. Eitan Medical Business Overview Table 132. Eitan Medical Wearable Injectors and Connected Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Eitan Medical Wearable Injectors and Connected Devices Product Portfolio Table 134. Eitan Medical Recent Development Table 135. CeQur Company Information Table 136. CeQur Business Overview Table 137. CeQur Wearable Injectors and Connected Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. CeQur Wearable Injectors and Connected Devices Product Portfolio Table 139. CeQur Recent Development Table 140. BD Medical Company Information Table 141. BD Medical Business Overview Table 142. BD Medical Wearable Injectors and Connected Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. BD Medical Wearable Injectors and Connected Devices Product Portfolio Table 144. BD Medical Recent Development Table 145. Amgen Company Information Table 146. Amgen Business Overview Table 147. Amgen Wearable Injectors and Connected Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. Amgen Wearable Injectors and Connected Devices Product Portfolio Table 149. Amgen Recent Development Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. Wearable Injectors and Connected Devices Distributors List Table 153. Wearable Injectors and Connected Devices Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Wearable Injectors and Connected Devices Product Image Figure 2. Global Wearable Injectors and Connected Devices Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Wearable Injectors and Connected Devices Sales Value (2021-2032) & (US$ Million) Figure 4. Global Wearable Injectors and Connected Devices Sales (2021-2032) & (k units) Figure 5. Global Wearable Injectors and Connected Devices Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Wearable Injectors and Connected Devices Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Disposable Image Figure 10. Reusable Image Figure 11. Global Wearable Injectors and Connected Devices Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Wearable Injectors and Connected Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Wearable Injectors and Connected Devices Sales Volume Share by Type (2021-2032) Figure 14. Global Wearable Injectors and Connected Devices Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Wearable Injectors and Connected Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Wearable Injectors and Connected Devices Sales Value Share by Type (2021-2032) Figure 17. Home Care Settings Image Figure 18. Hospitals Image Figure 19. Clinics Image Figure 20. Others Image Figure 21. Global Wearable Injectors and Connected Devices Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Wearable Injectors and Connected Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Wearable Injectors and Connected Devices Sales Volume Share by Application (2021-2032) Figure 24. Global Wearable Injectors and Connected Devices Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Wearable Injectors and Connected Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Wearable Injectors and Connected Devices Sales Value Share by Application (2021-2032) Figure 27. Global Wearable Injectors and Connected Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Wearable Injectors and Connected Devices Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Wearable Injectors and Connected Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Wearable Injectors and Connected Devices Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Wearable Injectors and Connected Devices Sales Value (2021-2032) & (US$ Million) Figure 32. North America Wearable Injectors and Connected Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Wearable Injectors and Connected Devices Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Wearable Injectors and Connected Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Wearable Injectors and Connected Devices Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Wearable Injectors and Connected Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Wearable Injectors and Connected Devices Sales Value (2021-2032) & (US$ Million) Figure 38. South America Wearable Injectors and Connected Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Wearable Injectors and Connected Devices Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Wearable Injectors and Connected Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Wearable Injectors and Connected Devices Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Wearable Injectors and Connected Devices Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Disposable
  • Reusable
Applications
  • Home Care Settings
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Roche
  • Ypsomed
  • West Pharma
  • United Therapeutics
  • Unilife Corporation
  • Sonceboz
  • ScPharmaceuticals
  • Owen Mumford
  • Noble International
  • Insulet
  • Gerresheimer
  • Enable Injections
  • Elcam Medical
  • Eitan Medical
  • CeQur
  • BD Medical
  • Amgen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Wearable Injectors and Connected Devices Sales Value (2021-2032)
  4. 1.2.2 Global Wearable Injectors and Connected Devices Sales Volume (2021-2032)
  5. 1.2.3 Global Wearable Injectors and Connected Devices Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Wearable Injectors and Connected Devices Market Dynamics
  1. 2.1 Wearable Injectors and Connected Devices Industry Trends
  2. 2.2 Wearable Injectors and Connected Devices Industry Drivers
  3. 2.3 Wearable Injectors and Connected Devices Industry Opportunities and Challenges
  4. 2.4 Wearable Injectors and Connected Devices Industry Restraints
3 Wearable Injectors and Connected Devices Market by Company
  1. 3.1 Global Wearable Injectors and Connected Devices Company Revenue Ranking in 2025
  2. 3.2 Global Wearable Injectors and Connected Devices Revenue by Company (2021-2026)
  3. 3.3 Global Wearable Injectors and Connected Devices Sales Volume by Company (2021-2026)
  4. 3.4 Global Wearable Injectors and Connected Devices Average Price by Company (2021-2026)
  5. 3.5 Global Wearable Injectors and Connected Devices Company Ranking (2024-2026)
  6. 3.6 Global Wearable Injectors and Connected Devices Company Manufacturing Base and Headquarters
  7. 3.7 Global Wearable Injectors and Connected Devices Company Product Type and Application
  8. 3.8 Global Wearable Injectors and Connected Devices Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Wearable Injectors and Connected Devices Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Wearable Injectors and Connected Devices Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Wearable Injectors and Connected Devices Market by Type
  1. 4.1 Wearable Injectors and Connected Devices Type Introduction
  2. 4.1.1 Disposable
  3. 4.1.2 Reusable
  4. 4.2 Global Wearable Injectors and Connected Devices Sales Volume by Type
  5. 4.2.1 Global Wearable Injectors and Connected Devices Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Wearable Injectors and Connected Devices Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Wearable Injectors and Connected Devices Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Wearable Injectors and Connected Devices Sales Value by Type
  9. 4.3.1 Global Wearable Injectors and Connected Devices Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Wearable Injectors and Connected Devices Sales Value by Type (2021-2032)
  11. 4.3.3 Global Wearable Injectors and Connected Devices Sales Value Share by Type (2021-2032)
5 Wearable Injectors and Connected Devices Market by Application
  1. 5.1 Wearable Injectors and Connected Devices Application Introduction
  2. 5.1.1 Home Care Settings
  3. 5.1.2 Hospitals
  4. 5.1.3 Clinics
  5. 5.1.4 Others
  6. 5.2 Global Wearable Injectors and Connected Devices Sales Volume by Application
  7. 5.2.1 Global Wearable Injectors and Connected Devices Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Wearable Injectors and Connected Devices Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Wearable Injectors and Connected Devices Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Wearable Injectors and Connected Devices Sales Value by Application
  11. 5.3.1 Global Wearable Injectors and Connected Devices Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Wearable Injectors and Connected Devices Sales Value by Application (2021-2032)
  13. 5.3.3 Global Wearable Injectors and Connected Devices Sales Value Share by Application (2021-2032)
6 Wearable Injectors and Connected Devices Regional Sales and Value Analysis
  1. 6.1 Global Wearable Injectors and Connected Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Wearable Injectors and Connected Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Wearable Injectors and Connected Devices Sales by Region: 2021-2026
  4. 6.2.2 Global Wearable Injectors and Connected Devices Sales by Region (2027-2032)
  5. 6.3 Global Wearable Injectors and Connected Devices Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Wearable Injectors and Connected Devices Sales Value by Region (2021-2032)
  7. 6.4.1 Global Wearable Injectors and Connected Devices Sales Value by Region: 2021-2026
  8. 6.4.2 Global Wearable Injectors and Connected Devices Sales Value by Region (2027-2032)
  9. 6.5 Global Wearable Injectors and Connected Devices Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Wearable Injectors and Connected Devices Sales Value (2021-2032)
  12. 6.6.2 North America Wearable Injectors and Connected Devices Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Wearable Injectors and Connected Devices Sales Value (2021-2032)
  15. 6.7.2 Europe Wearable Injectors and Connected Devices Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Wearable Injectors and Connected Devices Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Wearable Injectors and Connected Devices Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Wearable Injectors and Connected Devices Sales Value (2021-2032)
  21. 6.9.2 South America Wearable Injectors and Connected Devices Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Wearable Injectors and Connected Devices Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Wearable Injectors and Connected Devices Sales Value Share by Country, 2025 VS 2032
7 Wearable Injectors and Connected Devices Country-level Sales and Value Analysis
  1. 7.1 Global Wearable Injectors and Connected Devices Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Wearable Injectors and Connected Devices Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Wearable Injectors and Connected Devices Sales by Country (2021-2032)
  4. 7.3.1 Global Wearable Injectors and Connected Devices Sales by Country (2021-2026)
  5. 7.3.2 Global Wearable Injectors and Connected Devices Sales by Country (2027-2032)
  6. 7.4 Global Wearable Injectors and Connected Devices Sales Value by Country (2021-2032)
  7. 7.4.1 Global Wearable Injectors and Connected Devices Sales Value by Country (2021-2026)
  8. 7.4.2 Global Wearable Injectors and Connected Devices Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Wearable Injectors and Connected Devices Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Wearable Injectors and Connected Devices Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Wearable Injectors and Connected Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche Wearable Injectors and Connected Devices Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Roche Wearable Injectors and Connected Devices Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 Ypsomed
  8. 8.2.1 Ypsomed Company Information
  9. 8.2.2 Ypsomed Business Overview
  10. 8.2.3 Ypsomed Wearable Injectors and Connected Devices Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Ypsomed Wearable Injectors and Connected Devices Product Portfolio
  12. 8.2.5 Ypsomed Recent Developments
  13. 8.3 West Pharma
  14. 8.3.1 West Pharma Company Information
  15. 8.3.2 West Pharma Business Overview
  16. 8.3.3 West Pharma Wearable Injectors and Connected Devices Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 West Pharma Wearable Injectors and Connected Devices Product Portfolio
  18. 8.3.5 West Pharma Recent Developments
  19. 8.4 United Therapeutics
  20. 8.4.1 United Therapeutics Company Information
  21. 8.4.2 United Therapeutics Business Overview
  22. 8.4.3 United Therapeutics Wearable Injectors and Connected Devices Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 United Therapeutics Wearable Injectors and Connected Devices Product Portfolio
  24. 8.4.5 United Therapeutics Recent Developments
  25. 8.5 Unilife Corporation
  26. 8.5.1 Unilife Corporation Company Information
  27. 8.5.2 Unilife Corporation Business Overview
  28. 8.5.3 Unilife Corporation Wearable Injectors and Connected Devices Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Unilife Corporation Wearable Injectors and Connected Devices Product Portfolio
  30. 8.5.5 Unilife Corporation Recent Developments
  31. 8.6 Sonceboz
  32. 8.6.1 Sonceboz Company Information
  33. 8.6.2 Sonceboz Business Overview
  34. 8.6.3 Sonceboz Wearable Injectors and Connected Devices Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sonceboz Wearable Injectors and Connected Devices Product Portfolio
  36. 8.6.5 Sonceboz Recent Developments
  37. 8.7 ScPharmaceuticals
  38. 8.7.1 ScPharmaceuticals Company Information
  39. 8.7.2 ScPharmaceuticals Business Overview
  40. 8.7.3 ScPharmaceuticals Wearable Injectors and Connected Devices Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 ScPharmaceuticals Wearable Injectors and Connected Devices Product Portfolio
  42. 8.7.5 ScPharmaceuticals Recent Developments
  43. 8.8 Owen Mumford
  44. 8.8.1 Owen Mumford Company Information
  45. 8.8.2 Owen Mumford Business Overview
  46. 8.8.3 Owen Mumford Wearable Injectors and Connected Devices Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Owen Mumford Wearable Injectors and Connected Devices Product Portfolio
  48. 8.8.5 Owen Mumford Recent Developments
  49. 8.9 Noble International
  50. 8.9.1 Noble International Company Information
  51. 8.9.2 Noble International Business Overview
  52. 8.9.3 Noble International Wearable Injectors and Connected Devices Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Noble International Wearable Injectors and Connected Devices Product Portfolio
  54. 8.9.5 Noble International Recent Developments
  55. 8.10 Insulet
  56. 8.10.1 Insulet Company Information
  57. 8.10.2 Insulet Business Overview
  58. 8.10.3 Insulet Wearable Injectors and Connected Devices Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Insulet Wearable Injectors and Connected Devices Product Portfolio
  60. 8.10.5 Insulet Recent Developments
  61. 8.11 Gerresheimer
  62. 8.11.1 Gerresheimer Company Information
  63. 8.11.2 Gerresheimer Business Overview
  64. 8.11.3 Gerresheimer Wearable Injectors and Connected Devices Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Gerresheimer Wearable Injectors and Connected Devices Product Portfolio
  66. 8.11.5 Gerresheimer Recent Developments
  67. 8.12 Enable Injections
  68. 8.12.1 Enable Injections Company Information
  69. 8.12.2 Enable Injections Business Overview
  70. 8.12.3 Enable Injections Wearable Injectors and Connected Devices Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Enable Injections Wearable Injectors and Connected Devices Product Portfolio
  72. 8.12.5 Enable Injections Recent Developments
  73. 8.13 Elcam Medical
  74. 8.13.1 Elcam Medical Company Information
  75. 8.13.2 Elcam Medical Business Overview
  76. 8.13.3 Elcam Medical Wearable Injectors and Connected Devices Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Elcam Medical Wearable Injectors and Connected Devices Product Portfolio
  78. 8.13.5 Elcam Medical Recent Developments
  79. 8.14 Eitan Medical
  80. 8.14.1 Eitan Medical Company Information
  81. 8.14.2 Eitan Medical Business Overview
  82. 8.14.3 Eitan Medical Wearable Injectors and Connected Devices Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Eitan Medical Wearable Injectors and Connected Devices Product Portfolio
  84. 8.14.5 Eitan Medical Recent Developments
  85. 8.15 CeQur
  86. 8.15.1 CeQur Company Information
  87. 8.15.2 CeQur Business Overview
  88. 8.15.3 CeQur Wearable Injectors and Connected Devices Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 CeQur Wearable Injectors and Connected Devices Product Portfolio
  90. 8.15.5 CeQur Recent Developments
  91. 8.16 BD Medical
  92. 8.16.1 BD Medical Company Information
  93. 8.16.2 BD Medical Business Overview
  94. 8.16.3 BD Medical Wearable Injectors and Connected Devices Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 BD Medical Wearable Injectors and Connected Devices Product Portfolio
  96. 8.16.5 BD Medical Recent Developments
  97. 8.17 Amgen
  98. 8.17.1 Amgen Company Information
  99. 8.17.2 Amgen Business Overview
  100. 8.17.3 Amgen Wearable Injectors and Connected Devices Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Amgen Wearable Injectors and Connected Devices Product Portfolio
  102. 8.17.5 Amgen Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Wearable Injectors and Connected Devices Value Chain Analysis
  2. 9.1.1 Wearable Injectors and Connected Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Wearable Injectors and Connected Devices Sales Mode & Process
  6. 9.2 Wearable Injectors and Connected Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Wearable Injectors and Connected Devices Distributors
  9. 9.2.3 Wearable Injectors and Connected Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst